Export this record

Export record to excel

File type to download

Beta version

Select record 2

ArticlesPeer ReviewedFull Text

Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (...

Author / Creator:Mittendorf, Elizabeth A ; Zhang, Hong ; Barrios, Carlos H ; Saji, Shigehira ; Jung, Kyung Hae ; Hegg, Roberto ; Koehler, Andreas ; Sohn, Joohyuk ; Iwata, Hiroji ; Telli, Melinda L ; Ferrario, Cristiano ; Punie, Kevin ; Penault-Llorca, Frédérique ; Patel, Shilpen ; Duc, Anh Nguyen ; Liste-Hermoso, Mario ; Maiya, Vidya ; Molinero, Luciana ; Chui, Stephen Y ; Harbeck, Nadia

Publisher:England: Elsevier Ltd

Journal title:The Lancet (British edition), 2020-10, Vol.396 (10257), p.1090-1100

View online as a Library member

Export record to excel

Export this record

Export record to excel

Patient-reported outcomes from a randomized trial of neoadjuvant atezolizumab-chemotherapy in early triple-negative breast cancer

Export this record

Export record to excel

Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (...

Refine your search